Back to top

Citizens JMP downgrades Clearside Biomedical (CLSD) to a Hold

Clearside Biomedical received a Hold rating and price target from Citizens JMP analyst Jonathan Wolleben today. The company’s shares closed today a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Clearside Biomedical, Inc. (CLSD)